MOUNTAIN VIEW, Calif.,
Dec. 7, 2019 /PRNewswire/
-- Ceribell, Inc announced the launch of Clarity, a new 24/7
bedside EEG monitoring and alerting technology, at the American
Epileptology Society Annual Meeting. Ceribell's Rapid
Response EEG system made bedside EEG possible for critically ill
patients by simplifying the EEG system and reducing time from
ordering EEG to set-up from an average of 4 hours to under 10
minutes.
Ceribell is again revolutionizing EEG tools for critically ill
patients with the launch of the new Clarity technology. Used
with the Ceribell Rapid Response EEG, Clarity is the first and only
24/7 EEG monitoring and alerting system that automatically detects
seizures and alerts clinicians for the presence of brain activity
consistent with status epilepticus. The Ceribell Rapid
Response EEG with Clarity is the most accurate and easiest to use
EEG monitoring system on the market and the first bed-side alert
for continuous seizures. Its signal quality is equivalent to more
complex conventional systems, and it includes the Brain Stethoscope
feature to spot-check for seizures and Clarity for automatic and
continuous seizure monitoring.
"As we continue to drive innovation in the field of
encephalography, we are excited to bring the Clarity technology to
our Rapid Response EEG System for our customers," said Jane Chao, CEO, Ceribell. "When it comes
to EEG, there are significant unmet needs for greater access,
efficiency, and cost-effectiveness. Clarity will empower hospitals
to have the very best in 24/7 acute care EEG capability, at a
fraction of the cost of conventional systems. For the first time,
it is possible for physicians to detect non-convulsive status
epilepticus within minutes instead of waiting hours or days,
allowing them to provide the best care available so they can
minimize secondary brain injury."
TO LEARN MORE:
www.ceribell.com
ABOUT NON-CONVULSIVE STATUS EPILEPTICUS: TIME IS
BRAIN
Non-convulsive seizures are common in critically ill
patients. 90% of these seizures are non-convulsive and can
only be detected using EEG. Prolonged seizures of this type lead to
permanent brain injury, higher risk of morbidity and mortality, and
longer hospital stay. As a result, guidelines from the
Neurocritical Care Society recommend EEG should be initiated
within 15-60 minutes of suspected status epilepticus. However,
meeting this guideline has proven difficult due to limitations of
conventional EEG systems. The Ceribell Rapid Response EEG system
was developed to address limitations in EEG acquisition and
interpretation so patients at risk of seizure can be triaged more
quickly.
ABOUT THE CERIBELL RAPID RESPONSE EEG SYSTEM
The
Ceribell Rapid Response EEG System consists of a 10-electrode
(8-channel) headband, an EEG recorder with the Brain Stethoscope
feature, and a cloud portal for continuous seizure monitoring, EEG
data storing and remote EEG reviewing. The simplified electrode
configuration enables easy set-up of EEG within minutes without the
need for specialized training. With the Brain Stethoscope and
Clarity features, EEG interpretation for spot-checking and
continuous seizure detection are possible in just seconds.
The Ceribell EEG System received FDA 510(k) clearance in 2017
and is commercially available in the
United States.
ABOUT CERIBELL
Ceribell, Inc. (www.ceribell.com), is
headquartered in Mountain View,
CA. Ceribell is focused on making EEG widely available, more
efficient, and more cost-effective to improve the diagnosis and
treatment of patients at risk for seizures.
NOTE: Seizure detection notifications are not a substitute for
review of the underlying EEG by a trained expert.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/ceribell-announces-launch-of-clarity-providing-247-automatic-bedside-monitoring-to-enhance-eeg-capability-300970922.html
SOURCE Ceribell, Inc.